MRLs for ketoprofen in poultry
- Food safety
- Veterinary residues
Summary
The EU has set a maximum residue level (MRL) for ketoprofen in poultry tissues, but not in poultry eggs.
MRLs for ketoprofen set in poultry but not eggs
Commission Implementing Regulation (EU) 2023/2194 of 19 October 2023 amending Regulation (EU) No 37/2010 as regards the classification of the substance ketoprofen with respect to its maximum residue limit in foodstuffs of animal origin
Update
The EU has set a maximum residue level (MRL) for ketoprofen in poultry tissues, but not in poultry eggs.
Impacted Products
poultry
What is changing?
The European Commission has established MRLs for ketoprofen in poultry tissues:
- muscle, liver, kidney: 10 μg/kg
- skin and fat in natural proportion: 30 μg/kg.
There is no MRL for poultry that are producing eggs for human consumption, so ketoprofen may not be used in this case.
The Annex to Regulation 37/2010 on pharmacologically active substances and their MRLs in food of animal origin is amended accordingly.
Why?
The European Medicines Agency (EMA) concluded that the MRLs for ketoprofen from chicken tissues can be extended to tissues of other poultry, but not to poultry eggs. This is because no residue depletion data for ketoprofen in eggs were provided.
Timeline
Date of application: 9 November 2023.
What are the major implications for exporting countries?
Ketoprofen is now allowed in poultry meat tissues with an MRL of 10 μg/kg for muscle, liver, and kidney, and 30 μg/kg for skin and fat in natural proportion.
However, ketoprofen is still banned for poultry producing eggs for human consumption.
Recommended Actions
Countries that export poultry muscle, liver, kidney, and skin and fat in natural proportion must ensure that the established residue limits of ketoprofen in those products destined for the EU are not exceeded.
They must also ensure that ketoprofen is not used for poultry producing eggs for human consumption.
Background
The Annex to Regulation 37/2010 sets out the pharmacologically active substances and their MRLs in food of animal origin. It allows ketoprofen use for cattle, pigs, and horses. In December 2020, Huvepharma nv submitted an application to the EMA regarding MRLs for ketoprofen in chicken.
Resources
European Commission (2023) Control plans for residues of veterinary medicines, pesticides and contaminants.
European Commission: Residues of veterinary medicinal products
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.
MRLs for ketoprofen set in poultry but not eggs
Regulation 2023/2194 on classification of the substance ketoprofen with respect to its maximum residue limit in foodstuffs of animal origin
Regulation 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin
What is changing and why?
The EU has set maximum residue limits (MRLs) for the veterinary medicinal product ketoprofen in poultry tissues. The MRLs are:
- muscle, liver, kidney: 10 μg/kg
- skin and fat in natural proportion: 30 μg/kg.
There is no MRL for poultry that are producing eggs for human consumption as the necessary data has not been provided. Ketoprofen therefore may not be used for poultry producing eggs for human consumption.
Actions
Countries that export poultry tissue (muscle, liver, kidney, and skin and fat in natural proportion) to the EU must ensure that the established MRLs of ketoprofen are not exceeded.
They must also ensure that ketoprofen is not used for poultry that produce eggs for human consumption.
Timeline
Date of application: 9 November 2023.
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.